Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
June 8, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
June 8, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
June 8, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
June 8, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
June 8, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
June 8, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
June 8, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
June 8, 2023 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 7, 2023 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 6, 2023 S-8

Securities offered to employees pursuant to employee benefit plans

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us